Rafael Rosengarten, CEO of Genialis, recently joined The Biotech Startups Podcast to talk about his journey in biotech and the evolution of Genialis. Hosted by Jon Chee, CEO and Co-founder of Excedr, the conversation provides an insider’s perspective on the biotech startup landscape.

Rafael’s journey and growth of Genialis

Rafael’s conversation unfolds across four episodes, each exploring different phases of his career and Genialis’ growth. In Part 1, he shares his unconventional path into biotech, from early scientific curiosity to co-founding Genialis. Part 2 dives into the company’s origins; how a team of scientists and engineers came together to develop an AI-driven biomarker discovery platform and turn great science into a viable business.

The discussion continues in Part 3, where Rafael talks about the moment a biotech startup shifts from an idea to a company with customers, investors, and real-world impact. He covers fundraising, leadership, and the challenges of scaling Genialis. Finally, Part 4 tackles the big-picture questions: What’s next for AI in drug discovery? How can startups thrive in a competitive biotech landscape? And what advice does he have for the next generation of founders?

Listen to all four episodes

More conversations on the future of biotech

As part of the Bullpen’s run-up to JP Morgan, Rafael also had the pleasure of chatting with Kristen Revell about Genialis’ mission to transform medicine through data. That conversation, available here, delves into the role of AI in biomarker discovery and what’s next for precision medicine.